Development
Traws Pharma, Inc.
TRAW
$1.50
$0.021.35%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -20.18M | -20.84M | -20.62M | -18.96M | -17.31M |
| Total Depreciation and Amortization | 16.00K | 14.00K | 14.00K | 14.00K | 14.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.30M | 1.24M | 1.21M | 1.17M | 1.10M |
| Change in Net Operating Assets | 1.48M | 2.77M | 2.85M | 1.48M | -484.00K |
| Cash from Operations | -17.39M | -16.82M | -16.54M | -16.29M | -16.68M |
| Capital Expenditure | -14.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -35.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -35.00K |
| Foreign Exchange rate Adjustments | 31.00K | 13.00K | -6.00K | -19.00K | -55.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.37M | -16.80M | -16.55M | -16.31M | -16.77M |